%PDF-1.4
%
79 0 obj
<>
endobj
76 0 obj
<>
endobj
152 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-11-07T15:44:07Z
2024-03-28T18:07:51-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T18:07:51-07:00
application/pdf
Heather
2002-1021.dec
uuid:1a63870f-1dd2-11b2-0a00-220a27bd3700
uuid:1a638711-1dd2-11b2-0a00-5b0000000000
endstream
endobj
65 0 obj
<>
endobj
66 0 obj
<>
endobj
80 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 43 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 45 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 47 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 49 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 51 0 R/Type/Page>>
endobj
28 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 53 0 R/Type/Page>>
endobj
31 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 55 0 R/Type/Page>>
endobj
34 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 57 0 R/Type/Page>>
endobj
37 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 59 0 R/Type/Page>>
endobj
187 0 obj
[191 0 R]
endobj
188 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 1 K
/GS1 gs
54 54 m
558 54 l
S
BT
0 0 0 1 k
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 420.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:12)Tj
0 Tc 0 Tw -45.7952 -0.0313 Td
(2688)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 57 714.5293 Tm
[(34.)-875.1 (W)79.9 (eingarten S, Stone E, Hayward R, et al. )17.7 (The adoption of )]TJ
2.175 -1.25 Td
(preventive care practice guidelines by primary care physicians: do)Tj
0 -1.25 TD
(actions match intentions? J Gen Intern Med 1995;10:138-44.)Tj
-2.175 -1.25 Td
[(35.)-875.1 (Grimshaw JM, Russell IT)73.9 (. Ef)17.7 (fect of clinical guidelines on medical)]TJ
2.175 -1.25 Td
(practice: a systematic review of rigorous evaluations. Lancet)Tj
0 Tc 0 Tw T*
(1993;342:1317-22.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(36.)-875.1 (W)79.9 (oolf S. Practice guidelines: a new reality in medicine. Impact on)]TJ
2.175 -1.25 Td
[(patient care. )54.8 (Arch Intern Med 1993;153:2646-55.)]TJ
-2.175 -1.25 Td
[(37.)-875.1 (Lomas J, )54.8 (Anderson G, Dominick-Pierre K, )17.7 (V)110.8 (ayda E, Enkin M,)]TJ
2.175 -1.25 Td
[(Hannah )17.7 (W)91.8 (. Do practice guidelines guide practice? )17.7 (The ef)17.7 (fect of a)]TJ
T*
(consensus statement on the practice of physicians. N Engl J Med)Tj
0 Tc 0 Tw T*
[(1989;321:1306-1)36.9 (1.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(38.)-875.1 (Hayward RS, Guyatt GH, Moore KA, McKibbon KA, Carter )54.8 (AO.)]TJ
2.175 -1.25 Td
[(Canadian physicians\325)-201.1 (attitudes about and preferences regarding)]TJ
T*
[(clinical practice guidelines. Can Med )54.8 (Assoc J 1997;156:1715-23.)]TJ
-2.175 -1.25 Td
[(39.)-875.1 (T)35 (unis SR, Hayward RS, )17.7 (W)39.8 (ildon MC, et al. Internists\325)-201.1 (attitudes)]TJ
2.175 -1.25 Td
[(about clinical practice guidelines. )54.8 (Ann Intern Med )]TJ
0 Tc 0 Tw T*
(1994;120:956-63.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(40.)-875.1 (Davis DA, )17.7 (T)69.9 (aylor)19.7 (-V)110.8 (aisey )54.8 (A. )17.7 (T)35 (ranslating guidelines into practice. )54.8 (A)]TJ
2.175 -1.25 Td
(systematic review of theoretic concepts, practical experience and)Tj
T*
(research evidence in the adoption of clinical practice guidelines.)Tj
0 Tc T*
[(Can Med )54.8 (Assoc J 1997;157:408-16.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(41.)-875.1 (Cabana M, Rand C, Powe N, et al. )17.7 (Why don\325)17.7 (t physicians follow)]TJ
2.175 -1.25 Td
[(clinical practice guidelines?: )54.8 (A)-220.1 (framework for improvement. JAMA)]TJ
0 Tc 0 Tw T*
(1999;282:1458-65.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(42.)-875.1 (Hayward RS. Clinical practice guidelines on trial. Can Med )54.8 (Assoc )]TJ
0 Tc 2.175 -1.25 Td
(J 1997;156:1725-7.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(43.)-875.1 (Farquhar D. Recipes or roadmaps? Instead of rejecting clinical)]TJ
2.175 -1.25 Td
(practice guidelines as \322cookbook\323 solutions, could physicians use)Tj
T*
[(them as roadmaps for the journey of patient care? Can Med )54.8 (Assoc )]TJ
0 Tc T*
(J 1997;157:403-4.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(44.)-875.1 (W)79.9 (orrall G, Chaulk P)110.7 (, Freake D. )17.7 (The ef)17.7 (fects of clinical practice)]TJ
2.175 -1.25 Td
(guidelines on patient outcomes in primary care: a systematic)Tj
0 Tc T*
[(review)64.9 (. Can Med )54.9 (Assoc J 1997;156:1705-12.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(45.)-875.1 (Hartley RM, Charlton JR, Harris CM, Jarman B. Patterns of )]TJ
2.175 -1.25 Td
[(physicians\325)-201.1 (use of medical resources in ambulatory settings. )54.8 (Am )]TJ
T*
(J Publ Health 1987;77:565-7.)Tj
-2.175 -1.25 Td
[(46.)-875.1 (Mehl-Madrona LE. Frequent users of rural primary care: )]TJ
2.175 -1.25 Td
[(comparisons with randomly selected users. J )54.8 (Am Board Fam Pract)]TJ
0 Tc 0 Tw T*
[(1998;1)36.9 (1:105-15.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(47.)-875.1 (Patino FG, )54.8 (Allison J, Olivieri J, et al. )17.7 (The ef)17.7 (fects of physician)]TJ
2.175 -1.25 Td
(specialty and patient comorbidities on the use and discontinuation)Tj
T*
[(of coxibs. )54.8 (Arthritis Rheum 2003;49:293-9.)]TJ
-2.175 -1.25 Td
[(48.)-875.1 (Y)99.8 (elin E, Bernhard G, Pflugrad D. )54.8 (Access to medical care among)]TJ
2.175 -1.25 Td
[(persons with musculoskeletal conditions. )54.8 (A)-220.1 (study using a random)]TJ
T*
[(sample of households in San Mateo County)64.8 (, California. )54.8 (Arthritis)]TJ
0 Tc T*
[(Rheum 1995;38:1)36.9 (128-33.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(49.)-875.1 (Spitzer )17.7 (WO, Harth M, Goldsmith CH, et al. )17.7 (The arthritic complaint)]TJ
2.175 -1.25 Td
[(in primary care: prevalence, related disability)64.8 (, and costs. )]TJ
T*
(J Rheumatol 1976;3:88-99.)Tj
30.825 61.25 Td
[(50.)-875.1 (Kahl LE. Musculoskeletal problems in the family practice setting:)]TJ
2.175 -1.25 Td
[(guidelines for curriculum design. J Rheumatol 1987;14:81)36.8 (1-4.)]TJ
-2.175 -1.25 Td
[(51.)-875.1 (Donohoe MT)73.9 (. Comparing generalist and specialty care: )]TJ
2.175 -1.25 Td
[(discrepancies, deficiencies, and excesses. )54.8 (Arch Intern Med)]TJ
0 Tc 0 Tw T*
(1998;158:1596-608.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(52.)-875.1 (Solomon DH, Katz JN. Generalist, specialist, or both? J Rheumatol)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(2002;29:1345-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(53.)-875.1 (Allison JJ, )17.7 (W)79.9 (all )17.7 (TC, Spettell CM, et al. )17.7 (The art and science of chart)]TJ
2.175 -1.25 Td
[(review)64.8 (. Jt Comm J Qual Improv 2000;26:1)36.8 (15-36.)]TJ
-2.175 -1.25 Td
[(54.)-875.1 (Gilchrist )17.7 (WJ, Lee )36.8 (YC, )17.7 (T)69.9 (am HC, Macdonald JB, )17.7 (W)39.9 (illiams BO.)]TJ
2.175 -1.25 Td
(Prospective study of drug reporting by general practitioners for an)Tj
T*
(elderly population referred to a geriatric service. BMJ)Tj
0 Tc 0 Tw T*
(1987;294:289-90.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(55.)-875.1 (Beers MH, Munekata M, Storrie M. )17.7 (The accuracy of medication)]TJ
2.175 -1.25 Td
[(histories in the hospital medical records of elderly persons. J )54.8 (Am)]TJ
T*
[(Geriatr Soc 1990;38:1)36.8 (183-7.)]TJ
-2.175 -1.25 Td
[(56.)-875.1 (Jaski ME, Schwartzber)17.7 (g JG, Guttman RA, Noorani M. Medication)]TJ
2.175 -1.25 Td
[(review and documentation in physician of)17.7 (fice practice. Ef)17.7 (f Clin)]TJ
T*
(Pract 2000;3:31-4.)Tj
-2.175 -1.25 Td
[(57.)-875.1 (Lau HS, Florax C, Porsius )54.8 (AJ, De Boer )54.8 (A. )17.7 (The completeness of)]TJ
2.175 -1.25 Td
(medication histories in hospital medical records of patients)Tj
T*
(admitted to general internal medicine wards. Br J Clin Pharmacol)Tj
0 Tc 0 Tw T*
(2000;49:597-603.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(58.)-875.1 (Hannan )17.7 (TJ. Detecting adverse drug reactions to improve patient)]TJ
2.175 -1.25 Td
(outcomes. Int J Med Inf 1999;55:61-4.)Tj
-2.175 -1.25 Td
[(59.)-875.1 (Shenfield GM, Robb )17.7 (T)74 (, Duguid M. Recording previous adverse)]TJ
2.175 -1.25 Td
(drug reactions \321 a gap in the system. Br J Clin Pharmacol)Tj
0 Tc 0 Tw T*
(2001;51:623-6.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(60.)-875.1 (American College of Rheumatology Subcommittee on Rheumatoid)]TJ
2.175 -1.25 Td
(Arthritis Guidelines. Guidelines for the management of rheumatoid)Tj
T*
[(arthritis: 2002 update. )54.8 (Arthritis Rheum 2002;46:328-46.)]TJ
-2.175 -1.25 Td
[(61.)-875.1 (Hochber)17.7 (g MC, )54.8 (Altman RD, Brandt KD, et al. )54.8 (American College of)]TJ
2.175 -1.25 Td
(Rheumatology guidelines for the medical management of)Tj
T*
[(osteoarthritis. Part I. Osteoarthritis of the hip. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1995;38:1535-40.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(62.)-875.1 (Hochber)17.7 (g MC, )54.8 (Altman RD, Brandt KD, et al. )54.8 (American College of)]TJ
2.175 -1.25 Td
(Rheumatology guidelines for the medical management of)Tj
T*
[(osteoarthritis. Part II. Osteoarthritis of the knee. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1995;38:1541-6.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(63.)-875.1 (Eccles M, Freemantle N, Mason J. North of England evidence)]TJ
2.175 -1.25 Td
(based guideline development project: summary guideline for )Tj
T*
(non-steroidal anti-inflammatory drugs versus basic analgesia in)Tj
T*
[(treating the pain of degenerative arthritis. )17.7 (The North of England)]TJ
T*
[(Non-Steroidal )54.8 (Anti-Inflammatory Drug Guideline Development)]TJ
0 Tc T*
(Group. BMJ 1998;317:526-30.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(64.)-875.1 (US Preventive Services )17.7 (T)69.9 (ask Force. )54.8 (Aspirin for the primary )]TJ
2.175 -1.25 Td
(prevention of cardiovascular events: recommendation and rationale.)Tj
T*
(Ann Intern Med 2002;136:157-60.)Tj
-2.175 -1.25 Td
[(65.)-875.1 (Simon LS, Smolen JS, )54.8 (Abramson SB, et al. Controversies in )]TJ
2.175 -1.25 Td
(COX-2 selective inhibition. J Rheumatol 2002;29:1501-10.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
59 0 obj
<>stream
8;Z\6!H,h0#ikq,j?(hn_)<`6>HQ:2.;5cbGEdV4VXE3Ir@9\1j(eSlaXfUo*Bmhe
:V4Ii#Ab3OK=UcccitR3:dmECBn+7rPE#1MQK,2=Xj<_ZO#ek5@g0!g`k>
iF$pB=!j_6YN=m/e"[LEmU.i:jLKKZW(^1V[G^[<@V5t`?',L&]1d5#?G
0V+61lG+i^h9IWgF;[(f36lQ_^CT2I/V!g7;t_OlRT,tB+ZWo,*togtk=:1=!BjBe
]RM=jQsJr7(bR9T_j2+h,"i"gFMmPeli]cqBY$E\Cf4TA3\c=fC3c$rGHkdX.0r6Y
DXpgW#P($iTnVJ`F/3K+>0,Rc":b.XjLRO8&+ZAC(o/ch3PSiA`u(m5KrO)J3'e+T
^Ql)o\2MMJH`>C,q*D)T:8BHq`fCAeV#fe^;q*WFCE#STORIE1$"-7A*iag'ff:4u
())Z'c%L*^X3rl/-^qr\X@9Di^OlES1]@CO5a(amk$PC6#Y^L0L'OpoZ.mXO?(ldg
j\[N;.'WOG-In95.YGYJ4'Pmc^:?TDZA?HK7O.!PZq2]XN=M#Np$&Q:r,Tn>c:2EW
Q-sT[=;IIF-1/7QFnTE0c>"SV-.(sC*&^ck7S=--@K+M+7
+[!4+DcODdgU:tRrfGfSHR6a%`4)ank)G]t]TI&XDI3JG6#,V)~>
endstream
endobj
63 0 obj
[/Indexed/DeviceRGB 255 62 0 R]
endobj
62 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
82 0 obj
<>
endobj
88 0 obj
<>
endobj
123 0 obj
<>
endobj
157 0 obj
<>
endobj
89 0 obj
<>
endobj
117 0 obj
<>stream
H|TkTWQq&ݳAT*,$GbPpAT`30j$(<"*<P^*Lx)&F(dW7Y]Mr&W@r쯽uN[W:nj0>~CJviJ)K>`5,[#܄119䉒͂dM`
w*9FXU''eNNg)1RgwK.UE˥ҵ)rVҨUYBDlE/t/ԂꝜx#vZX!Ad!ujAh gi-6?yO)d+Lybyi\AF.@"]w7&qCוcwl ɂqzJn%iu|46uW~Oxo27bKDŶ8d(nd߷}w%[dRjrjoGGw4W^G^9U?xTX)xFw]rɂTђuGn=V;'>4CTe:}!RIg2G+>3`ZTyL5F`/-0S$rvX744/"h-
bEJv_ mkdS<"RV+> :ޜVY4&m؛Oآ----/)*LK8[X&;m=ٔUU]NJKH:ԙխOM-H)J={<5dٹWYd˚V)Z388+u}P1>CM#P#h@=Ԡ@;zհyfz:A@k:AR*kMMu[յIap=&$ F2BEI~ʬ?O(pр"_LgBX
8PEhk{A6cpDhflYQ^锑 IHxDGf{bupTQYHߝm*dDy{8<{Bn}`"K9SK1{$vG4 9rF?4.o_}|
1E0xꮛw{}bwDwtھFKo0dj.0?\gc1cRֿ;4uv0>\0C/CQaT=͐BHd$&s⯏%DCu偣&-RRGr;lYlrfzdCS$iB.x,G/0964q"Ypd>wfPT2GN(Am?LrhVDD{˩ƣB4FU pE8f~tdՅzëz(S:eMhQyyTd9LtS:֎N$C?]PX_P Fua?u7V